<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10797927</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Ortega, J</dc:author>
<dc:author>Campistol, J</dc:author>
<dc:author>Fernández, A</dc:author>
<dc:description xml:lang="en">INTRODUCTION The treatment in the acute phase of seizures and status epilepticus is a neurological emergency situation. Aggressive treatment and resuscitation maneuvers against the seizure may be required to avoid progression towards status epilepticus, with the high risk for the patients outcome this involves. DEVELOPMENT The use of rectal diazepam has supposed a great advance in the management of acute seizures. Intravenous sodium valproate has become available in these last years to control seizures and status epilepticus. Given at 20 mg/kg as single dose and with maintenance rate of 1 mg/kg/hour by intravenous infusion in 19 paediatric patients (1 day-7 years) status epilepticus was controlled in 58%, with reduction of status in 26%. Tolerance was good and there was no evidence of important adverse effects. CONCLUSION In view of our experience, we present a new protocol for the treatment of seizures and status epilepticus in childhood.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Aug 16-31 </dc:date>
<dc:title xml:lang="es">Estado de mal convulsivo en el niño. Experiencia con valproato endovenoso. Actualización del protocolo de tratamiento.</dc:title>
<dc:title xml:lang="en">[Status epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines].</dc:title>
<dc:publisher>Revista de neurologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
